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ABSTRACT
Background: Esophageal varices is the most common complication in liver cirrhosis. Bleeding varices is a 
serious complication causing increased mortality rate. In anticipation of those complications, the role of screening 
test is essential. Endoscopy is the standard method for assessing esophageal varices, but it carries certain 
risks for patients if it is contraindicated. Moreover, it is an invasive, expensive and uncomfortable procedure. 
Accordingly, a non-invasive method, aspartat aminotransferase to platelet ratio index (APRI) score, has been 
developed for evaluating esophageal varices. 
 Method: An analytic cross-sectional observational study was conducted in patients with liver cirrhosis 
who underwent endoscopy between March 2011 and August 2012. Data were obtained from medical records of 
hospitalized patients in Mohammad Hoesin General Hospital. The degree of esophageal varices was assessed 
based on endoscopic findings and APRI score. Spearman test was performed to analyze the correlation between 
APRI score and the degree of esophageal varices.
Results: There were 55 patients, 30 (54.5%) male and 25 (45.5%) female patients, with a range of age between 
15-70 years and a mean value of age of 47.09 ± 12.8. APRI score < 0.5 was found in 21.81% subjects, APRI score 
of 0.5-1.5 was obtained in 41.81% subjects and APRI score > 1.5 was noted in 36.36% subjects with a mean value 
of 2.32 ± 3.92. There was a correlation between APRI score and degree of esophageal varices with p = 0.011 
Conclusion: APRI score can indirectly predict esophageal varices in patients with liver cirrhosis.
Keywords: APRI score, the degree of esophageal varices, liver cirrhosis
ABSTRAK
Latar belakang: Varises esofagus merupakan penyulit paling sering pada sirosis hati. Perdarahan varises 
esofagus merupakan komplikasi serius karena dapat meningkatkan mortalitas. Oleh karena itu skrining varises 
esofagus penderita sirosis hati penting untuk mengantisipasi penyulit. Endoskopi merupakan salah satu metode 
untuk menilai varises esofagus, tetapi beresiko pada penderita yang mengalami kontraindikasi karena bersifat 
invasif, mahal dan kurang nyaman. Berdasarkan hal ini, maka dikembangkan metode non invasif seperti skor 
aspartat aminotransferase to platelet ratio index (APRI) untuk menilai varises esofagus. Tujuan penelitian untuk 
menilai korelasi antara skor APRI dengan derajat varises esofagus penderita sirosis hati.
 Metode: Penelitian observasi analitik dengan desain penelitian potong silang pada penderita sirosis hati 
yang menjalani prosedur pemeriksaan endoskopi dari Maret 2011 sampai Agustus 2012. Data diperoleh dari 
rekam medik pasien rawat inap di Rumah Sakit Muhammad Hoesin. Derajat varises esofagus dinilai dari hasil 
endoskopi serta skor APRI. Dilakukan tes Spearman untuk menganalisis korelasi antara skor APRI dengan 
derajat varises esofagus.
 Hasil: Terdapat 55 penderita sirosis hati terdiri dari laki-laki 30 (54,5%) dan perempuan 25 (45,5%) dengan 
usia antara 15 – 70 tahun, rerata 47,09 ± 12,8. Didapatkan skor APRI < 0,5 = 21,81%, skor APRI 0,5 – 1,5 
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= 41,81% dan skor APRI > 1,5 = 36,36% dengan rerata 2,32 ± 3,92. Didapatkan penderita varises esofagus 
derajat I sebanyak 15 (27,3%), derajat II sebanyak 20 (36,4%), derajat III sebanyak 15 (27,3%) dan derajat 
IV sebanyak 5 (9,1%). Diketahui terdapat korelasi antara skor APRI dengan derajat varises esofagus dengan 
p = 0,011.
 Simpulan: Terdapat korelasi antara skor APRI dengan derajat varises esofagus penderita sirosis hati.
Kata kunci: skor APRI, derajat varises esofagus, sirosis hati
INTRODUCTION
Liver cirrhosis is the end stage of chronic liver 
disease characterized by the presence of several 
complications caused by portal hypertension. 
Esophageal varices is a frequent complication of 
cirrhosis with incidence rates reach 90%.1 Bleeding 
from esophageal varices is a serious and dangerous 
complication with incidence of 5% on small varicose 
veins and 15% at large ones. Mortality rate due to 
variceal bleeding episode is about 10-20% and the life 
expectancy is around 63%.2,3 Therefore, screening of 
esophageal varices in patients with liver cirrhosis is 
essential to anticipate the complications that arise.3,4
 The method currently used for screening of esophageal 
varices is endoscopic examination performed every 2-3 
years in patients with liver cirrhosis without varices and 
every 1-2 years in patients with small varices. Endoscopy 
is an invasive, less expensive and less acceptable 
method. Therefore, screening test for patients with large 
esophageal varices who have high bleeding risk will be 
a growing problem. To overcome the problem, some 
experts have developed several non-invasive methods 
such as serum markers, ultrasonography and transient 
elastrography, which can be used as alternative measures 
to assess the presence of esophageal varices indirectly.5
 Based on the concept that the occurrence of portal 
hypertension is due to hepatic fibrosis, an important 
factor that results in vascular resistance in the liver, then 
the non-invasive examination of serum markers can be 
used to predict esophageal varices in liver cirrhosis 
with good results.6,7 Aspartate aminotransferase to 
platelet ratio index (APRI) score is one of the serum 
markers that can be used to assess the presence of 
liver fibrosis. APRI score can be obtained from the 
calculation of two laboratory results, namely the 
aspartate aminotransferase (AST) level and platelet 
counts. APRI score has an advantage in that it only 
covers two laboratory tests, which are low cost and 
routinely performed for all patients.8 The purpose of 
our study was to determine the correlation between 
APRI score and the degree of esophageal varices in 
patients with liver cirrhosis.
METHOD
This study design was observational, analytic 
and cross-sectional conducted in patients with liver 
cirrhosis who underwent endoscopic procedure in 
Mohammad Hoesin Hospital, Palembang between 
March 2011 and August 2012. Data were retrieved 
from medical records of hositalized patients with liver 
cirrhosis in the hospital. Diagnosis of liver cirrhosis 
was established based on clinical findings and results 
of laboratory and ultrasound examinations. Symptoms 
of liver cirrhosis usually include enlarged stomach and 
leg swelling, weakness, loss of appetite, weight loss, 
satiety, epigastric discomfort, nausea, bloating, upper 
right abdominal pain, vomiting blood and passage of 
black stool. Signs of liver cirrhosis were associated 
with failure of liver function and the presence of portal 
hypertension. Laboratory results might indicate the 
presence of anemia, thrombocytopenia, hemostasis 
disorders, liver dysfunction, hypoalbuminemia, 
electrolyte disturbances and the presence of serological 
markers for viral hepatitis.
Ultrasonography included examination on the 
size, the structure of liver parenchyma, the liver 
edge, homogeneity and presence of mass. In patients 
who have advanced liver cirrhosis, their liver 
ultrasonography would showed a smaller size and 
presence of nodules, uneven surfaces, as well as an 
increase in parenchymal echogenicity.9 
 APRI score is an index ratio of aspartate 
aminotransferase (AST) and platelets counts. Wai CT 
et al formulate the equation as follows: 
Aspartate aminotransferase (AST)/upper normal limit x 100
Platelet counts (109/L)
APRI score value of < 0.5 indicated no or minimal 
fibrosis, APRI score from 0.5 to 1.5 indicated significant 
fibrosis and APRI score  > 1.5 indicated liver cirrhosis.8
Examinations of esophageal varices were 
performed using Olympus® GIF Q 150 endoscope. 
There are several methods to determine the degree 
of esophageal varices. In this study, the degree of 
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esophageal varices was determined by subjective 
methods, which divided into esophageal varices into: 
(1) grade I when small veins were seen with valsava 
maneuvering; (2) grade II if varices was found with 
a diameter of 1-3 mm; (3) grade III when varices was 
3-6 mm in size and (4) grade IV when the varices 
size was > 6 mm.
Inclusion criteria for this study were: (1) all 
patients with liver cirrhosis. The diagnosis was 
established based on clinical symptoms, laboratory 
and ultrasound results; (2) patients with esophageal 
varices evaluated by endoscopic examination. 
Exclusion criteria were patients with a history of 
variceal ligation and sclerotherapy, a thrombus in 
portal vein ultrasonography, history of taking beta-
blockers, nitrates, hepatoprotective and antifibrotic 
agents. 
Spearman correlation test was used to analyze the 
correlation between APRI score and the degree of 
esophageal varices with p < 0.05 considered as the 
significance limit. Statistical analysis was performed 
using SPSS version 2.0. 
RESULTS
In this study, there were 55 patients with liver 
cirrhosis who underwent endoscopy, consisting of 30 
(54.5%) male and 25 (45.5%) female patients with the 
age range of 15-70 years and a mean age of 47.09 ± 
12.8. The major causes of patients with liver cirrhosis 
were hepatitis B virus (61.8%) and hepatitis C virus 
(7.3%). Patient characteristics are shown in Table 1. 
Data on the degree of esophageal varices were 
obtained. There were 15 (27.3%) patients with of 
patients with esophageal varices grade I, 20 (36.4%) 
patients with grade II, 15 (27.3%) patients with grade 
III, and 5 (9.1%) patients with grade IV esophageal 
varices with a mean value of 2.18 ± 0.94. APRI score 
< 0.5 was found in 12 (21.81%) patients, APRI score 
of 0.5-1.5 was obtained in 23 (41.81%) patients and 
APRI score > 1.5 was noted in 12 (36.36%) patients 
with a mean value of 2.32 ± 3.92 (Figure 1 and 2). 
The statistical Spearman test showed a correlation 
between APRI score and the degree of esophageal 
varices in patients with liver cirrhosis with p = 0.011 
(p < 0.05).
DISCUSSION
Esophageal varices is one of complications of portal 
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liver cirrhosis.10 Assessment of esophageal varices degree can be done indirectly by 
identifying liver fibrosis. Several methods can be used to assess liver fibrosis 
indirectly by using serum markers such as fibrotest, fibro index, APRI score, Lok 
score, Forns index, etc.11 APRI score has several advantages compared with other 
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Table 1. Characteristics of patients










Albumin (mg/dL) 2.60 ± 0.68
Globulin (mg/dL) 3.79 ± 1.10
Platelet (109/L) 153.74 ± 12.8
AST (17 - 327 IU/L) 83.22 ± 68.29
ALT (11 - 344 IU/L) 57.4 ± 58.93
Indirect bilirubin 
(0.26 - 11.72 mg/dL) 
1.47 ± 2.24
Direct bilirubin 
(0.12 - 31.70 mg/dL) 
3.50 ± 6.24
Etiology
HbsAg positive 34 (61.8)





Figure 1. Frequency of APRI Score 
 
 
Figure 2. Degree of esophageal varices 
 
DISCUSSION 
      Esophageal varices is one of complications of portal hypertension caused by 
liver cirrhosis.10 Assessment of esophageal varices degree can be done indirectly by 
identifying liver fibrosis. Several methods can be used to assess liver fibrosis 
indirectly by using serum markers such as fibrotest, fibro index, APRI score, Lok 
score, Forns index, etc.11 APRI score has several advantages compared with other 
indirect markers because it is cheaper, easy to performed and routinely examined in 
all patients with liver cirrhosis.8 
Figure 2. Degree of esophageal varices
AST: aspartate aminotransferase; ALT: alanine transaminase; HCV: hepatitis 
C virus
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markers such as fibrotest, fibro index, APRI score, 
Lok score, Forns index, etc.11 APRI score has several 
advantages compared with other indirect markers 
because it is cheaper, easy to performed and routinely 
examined in all patients with liver cirrhosis.8
Several studies have shown that APRI score can be 
used to depict hepatic fibrosis. Shaheen et al reported 
the identification of fibrosis in patients with chronic 
hepatitis C virus infection, APRI score < 0.5 had a 
negative predictive value (NPV) of 72%, while the 
APRI score >1.5 had a positive predictive value (PPV) 
of 87%.12 Wai CT et al concluded that APRI score can 
predict accurately significant fibrosis and cirrhosis in 
51% and 81% respectively, potentially avoiding the 
need for liver biopsis in patients.13
Study on the prediction of esophageal varices by 
non-invasive parameters is very important in order 
to avoid endoscopy which is an invasive, expensive, 
and less convenient procedure for every liver cirrhotic 
patient. Thabut et al, in their manuscript on the non-
invasive assessment of portal hypertension have 
stressed out the role of serum markers in establishing 
diagnosis of esophageal varices in the future. 
Therefore, the cheaper, easier and higher sensitivity 
and specificity marker is required.14
In our study, most patients had second grade 
esophageal varices (36.4%) and APRI score from 0.5 
to 1.5 was found as much as 41.81%. The statistical 
Spearman test showed a correlation between APRI 
score and the degree of esophageal varices with 
p = 0.011 (p < 0.05). The results are similar to previous 
study results, which show a correlation between APRI 
score and esophageal varices. Tafarel et al examined 
300 patients with liver cirrhosis and they also found a 
correlation between APRI score and esophageal varices 
(p = 0.02).15 Sanyal et al in 2006 examined 1,016 
patients with compensated liver cirrhosis and reported 
a correlation between APRI score and the presence 
of esophageal varices (p = 0.01).16 Sebastian et al got 
strong correlation between APRI score in the presence 
of esophageal varices (APRI = 1.4, sensitivity 54%, 
specificity 69%) and on a large varices (APRI score = 
15, sensitivity 59% and specificity 63%).7
CONCLUSION
There is a correlation between APRI score and the 
degree of esophageal varices. APRI score can indirectly 
predict the degree of esophageal varices in patients 
with liver cirrhosis.
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